Novavax (NVAX) Other Non-Current Assets (2010 - 2026)

Novavax's Other Non-Current Assets history runs 17 years deep, the most recent figure standing at $16.0 million for Q1 2026.

• In Q1 2026, Other Non-Current Assets fell 27.18% year-over-year to $16.0 million; the TTM figure through Mar 2026 stood at $16.0 million (down 27.18% YoY), while the FY2025 annual figure was $17.1 million, down 28.85% from the prior year.
• Other Non-Current Assets was $16.0 million for Q1 2026 at Novavax, down from $17.1 million in the prior quarter.
• In the past five years, Other Non-Current Assets ranged from a high of $35.2 million in Q4 2023 to a low of $16.0 million in Q1 2026.
• Historically, Other Non-Current Assets has averaged $25.4 million across 5 years, with a median of $24.0 million in 2024.
• The sharpest annual moves came in 2022 and 2023: Other Non-Current Assets sank 54.6% in 2022, then jumped 100.45% in 2023.
• A 5-year view of Other Non-Current Assets shows it stood at $28.5 million in 2022, then advanced by 23.5% to $35.2 million in 2023, then plunged by 31.74% to $24.0 million in 2024, then slipped by 28.85% to $17.1 million in 2025, then slipped by 6.59% to $16.0 million in 2026.
• The last three Other Non-Current Assets figures came in at $16.0 million (Q1 2026), $17.1 million (Q4 2025), and $19.2 million (Q3 2025), per Business Quant data.